Cargando…
Ketone Bodies Promote Amyloid-β(1–40) Clearance in a Human in Vitro Blood–Brain Barrier Model
Alzheimer’s disease (AD) is characterized by the abnormal accumulation of amyloid-β (Aβ) peptides in the brain. The pathological process has not yet been clarified, although dysfunctional transport of Aβ across the blood–brain barrier (BBB) appears to be integral to disease development. At present,...
Autores principales: | Versele, Romain, Corsi, Mariangela, Fuso, Andrea, Sevin, Emmanuel, Businaro, Rita, Gosselet, Fabien, Fenart, Laurence, Candela, Pietra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037612/ https://www.ncbi.nlm.nih.gov/pubmed/32023814 http://dx.doi.org/10.3390/ijms21030934 |
Ejemplares similares
-
TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model
por: Versele, Romain, et al.
Publicado: (2022) -
A Miniaturized Pump Out Method for Characterizing Molecule Interaction with ABC Transporters
por: Sevin, Emmanuel, et al.
Publicado: (2019) -
The Blood–Brain Barrier, an Evolving Concept Based on Technological Advances and Cell–Cell Communications
por: Menaceur, Camille, et al.
Publicado: (2021) -
New Lipidyl-Cyclodextrins Obtained by Ring Opening of Methyl Oleate Epoxide Using Ball Milling
por: Oliva, Estefania, et al.
Publicado: (2020) -
Impact of Pesticide Residues on the Gut-Microbiota–Blood–Brain Barrier Axis: A Narrative Review
por: Abou Diwan, Maria, et al.
Publicado: (2023)